|
Generic Name : Vildagliptin
Therapeutic Classification : antidiabetics
Trade Name(s):
India- Jalra, Zomelis. International- Eucreas, Galvumet, Galvus, Icandra, Jalra, Xiliarx. This medication is an oral antidiabetic agent, prescribed for type 2 diabetes mellitus along with other medications. When it is not to be taken (Contraindications):
When it is to be taken : PO- with metformin or a thiazolidinedione: 50 mg twice daily; with a sulfonylurea: 50 mg/day in the morning. Maximum: 100 mg/day. How it should be taken : It comes as a tablet to take by mouth, with food. Special Instruction : * Caution should be exercised in patients with history of severe kidney disease. * It may cause dizziness or fatigue, do not drive a car or operate machinery while taking this medication. * Patient may develop with increased risk of foot ulcers and blistering of the skin; if it is so consult with your doctor. * Monitor liver function and blood sugar level regularly while taking this medication. Side Effects : Most Common - Low blood sugar level, tremor, headache, weight gain and fluid retention. Central Nervous System - Dizziness, fatigue, and feeling weak. * Avoid excess dosage. Storage Conditions : Store it at room temperature (25 to 30°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||


